Janux Therapeutics Inc (NASDAQ: JANX) – Suitable For Long Term Buy?
Currently, there are 52.34M common shares owned by the public and among those 42.67M shares have been available to trade. The company’s stock has a 5-day price change of 22.61% and 34.61% over the past three months. JANX shares are trading 457.88% year to date (YTD), with the 12-month market performance up to 562.17% higher. […]
